Thymalfasin

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51202400
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51202421

Used in the treatment of B-cell acute lymphoblastic leukemia [ALL] treatment

Same parent

Under 51202400 · 21

51202401 Adalimumab Commodity 51202402 Basiliximab Commodity 51202403 Belimumab Commodity 51202404 Canakinumab Commodity 51202405 Certolizumab Commodity 51202406 Certolizumab pegol Commodity 51202407 Dacliximab or daclizumab Commodity 51202408 Eculizumab Commodity 51202409 Infliximab Commodity 51202410 Muromonab cd3 Commodity 51202411 Natalizumab Commodity 51202412 Omalizumab Commodity 51202413 Secukinumab Commodity 51202414 Ustekinumab Commodity 51202415 Ramucirumab Commodity 51202416 Daratumumab Commodity 51202417 Golimumab Commodity 51202418 Siltuximab Commodity 51202419 Dinutuximab Commodity 51202420 Polygala fluid extract Commodity 51202421 Thymalfasin You are here

Activities that produce or sell this

KBLI · 8

Inherited from family 51200000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.